FLUARIX QUADRIVALENT Rx
Generic Name and Formulations:
Quadrivalent inactivated "split virus" influenza vaccine (types A and B); contains a total of 60mcg hemagglutinin per 0.5mL dose; formulation changes annually; susp for IM inj; may contain trace amounts of hydrocortisone, gentamicin, others; preservative-free.
Indications for FLUARIX QUADRIVALENT:
Adults and Children:
<6mos: not established. Each dose is 0.5mL by IM inj once in the anterolateral thigh (6–11mos) or the deltoid (≥12mos). 6mos–8yrs (previously unvaccinated): 2 doses, give at least 4 weeks apart; (vaccinated in a previous season): 1 or 2 doses (depending on vaccination history as per annual ACIP recommendation); if 2 doses, give at least 4 weeks apart. ≥9yrs: 1 dose.
Allergy to egg protein. Life-threatening reaction to any previous flu vaccine.
Use current formulation only. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Bleeding disorders. Immunosuppressed. Risk of sycope with injectable vaccines. Have epinephrine inj (1:1000) available. Pregnancy. Nursing mothers.
Concomitant vaccines: insufficient data (see full labeling). Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may result in suboptimal response.
Local reactions (eg, redness, swelling, pain), muscle aches, fatigue, headache, arthralgias, GI symptoms, shivering, fever; children: irritability, loss of appetite, drowsiness.
Single-dose prefilled Tip-Lok syringes (0.5mL)—10
Clinical Pain Advisor Articles
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Stat Consult: Chronic Low Back Pain
- Opioid Misuse May Help Predict Alcohol Dependence Treatment Outcomes
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- OnabotulinumtoxinA May Be Effective for Chronic Migraine With Medication Overuse
- FDA Outlines Plan for Increasing Nonprescription Drug Availability
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Hypoesthesia for Touch and Joint Position Linked to Chronic Pain in MS
- New Laws Are Needed to Protect Health Data Shared Online